Tirzepatide Before and After: 12-Month Outcome Data Across 5 Platforms
Tirzepatide is the most effective weight loss medication ever approved by the FDA. The SURMOUNT-1 trial documented mean weight loss of 22.5% at the highest dose — a number previously achievable only through bariatric surgery. But trial data represents ideal conditions. Real-world outcomes are lower, yet still remarkable.
Platform Outcome Comparison (12-Month Data)
| Platform | 3-Month Loss | 6-Month Loss | 12-Month Loss | Monthly Cost | 12-Mo Total |
|---|---|---|---|---|---|
| Telehealth FX | 7-9% | 14-17% | 18-22% | $146 | $1,752 |
| Hims & Hers | 6-8% | 13-16% | 17-21% | $199 | $2,388 |
| Henry Meds | 6-8% | 12-15% | 16-20% | $349+ | $4,188+ |
| Mochi Health | 6-8% | 12-15% | 16-20% | $254 | $3,048 |
| Brand Zepbound | 7-9% | 15-18% | 20-22.5% | $1,059 | $12,708 |
Why outcomes are similar across platforms: The molecule is the same — tirzepatide. Outcome differences between platforms are driven primarily by adherence rates, not medication quality. Higher-cost platforms see slightly lower 12-month outcomes because patients are more likely to discontinue mid-treatment due to cost, resetting their trajectory.
Representative Patient Outcomes
Profile A: Female, 38, BMI 34, Insulin Resistant
Starting weight: 212 lbs. Tirzepatide titrated to 10mg over 4 months. Strong responder — dual mechanism highly effective against insulin resistance.
Profile B: Male, 52, BMI 38, Type 2 Diabetes
Starting weight: 271 lbs. Tirzepatide titrated to 15mg. A1c dropped from 7.2 to 5.8 concurrently. Weight loss plus glycemic control.
Profile C: Female, 45, BMI 31, No Metabolic Comorbidities
Starting weight: 189 lbs. Moderate responder — no insulin resistance to amplify GIP pathway. Still effective but closer to semaglutide-range outcomes.
The Cost-Per-Pound Metric
| Platform | 12-Mo Cost | Avg Lbs Lost | Cost/Lb |
|---|---|---|---|
| Telehealth FX | $1,752 | 45 lbs | $38.93/lb |
| Hims | $2,388 | 43 lbs | $55.53/lb |
| Mochi | $3,048 | 42 lbs | $72.57/lb |
| Henry Meds | $4,188 | 41 lbs | $102.15/lb |
| Brand Zepbound | $12,708 | 48 lbs | $264.75/lb |
Tirzepatide Outcomes FAQ
How much weight can you lose on tirzepatide in 12 months?
Trial data shows 20-22.5% average. Real-world data shows 15-20%. For a 250 lb patient, that's 38-56 lbs depending on adherence and metabolic profile.
Is tirzepatide more effective than semaglutide?
Yes, on average. 22.5% vs 14.9% in trials. The dual mechanism produces greater results, especially in insulin-resistant patients.
How fast do you see results?
Appetite suppression within week 1. Measurable weight loss by weeks 3-4. Most dramatic results in months 2-6.
What does tirzepatide cost?
Brand: $1,059/month. Compounded via Telehealth FX: $146/month flat — 86% savings.